TR200102839T2 - LH agonistleri olarak faydalı bisiklik heteroaromatik bileşikler. - Google Patents

LH agonistleri olarak faydalı bisiklik heteroaromatik bileşikler.

Info

Publication number
TR200102839T2
TR200102839T2 TR2001/02839T TR200102839T TR200102839T2 TR 200102839 T2 TR200102839 T2 TR 200102839T2 TR 2001/02839 T TR2001/02839 T TR 2001/02839T TR 200102839 T TR200102839 T TR 200102839T TR 200102839 T2 TR200102839 T2 TR 200102839T2
Authority
TR
Turkey
Prior art keywords
agonists
bicyclic heteroaromatic
compounds useful
heteroaromatic compounds
bicyclic
Prior art date
Application number
TR2001/02839T
Other languages
English (en)
Inventor
Geziena Gerritsma Gerrildina
Corine Ren�E Van Straten Nicole
Egbert Peter Adang Anton
Original Assignee
Akzo Nobel N. V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel N. V. filed Critical Akzo Nobel N. V.
Publication of TR200102839T2 publication Critical patent/TR200102839T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Abstract

Bulus genel formül (I)' e sahip bisiklik heteroaromatik bir türev bilesigine veya bunun farmasötik olarak kabul edilebilir bir tuzuna iliskindir. Bulusun bilesikleri, LH reseptörünü etkin hale getiren bir etkiye sahiptirler ve fertilite düzenleyici tedavilerde kullanilabilirler.
TR2001/02839T 1999-04-08 2000-04-03 LH agonistleri olarak faydalı bisiklik heteroaromatik bileşikler. TR200102839T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99201152 1999-04-08

Publications (1)

Publication Number Publication Date
TR200102839T2 true TR200102839T2 (tr) 2002-04-22

Family

ID=8240094

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/02839T TR200102839T2 (tr) 1999-04-08 2000-04-03 LH agonistleri olarak faydalı bisiklik heteroaromatik bileşikler.

Country Status (30)

Country Link
US (2) US6569863B1 (tr)
EP (1) EP1171443B1 (tr)
JP (1) JP4854856B2 (tr)
KR (1) KR100691546B1 (tr)
CN (1) CN1177848C (tr)
AR (1) AR028474A1 (tr)
AT (1) ATE299507T1 (tr)
AU (1) AU772258B2 (tr)
BR (1) BRPI0009558B1 (tr)
CA (1) CA2368834C (tr)
CO (1) CO5160348A1 (tr)
CZ (1) CZ300832B6 (tr)
DE (1) DE60021262T2 (tr)
DK (1) DK1171443T3 (tr)
ES (1) ES2245304T3 (tr)
HK (1) HK1041266B (tr)
HU (1) HU229002B1 (tr)
ID (1) ID30502A (tr)
IL (2) IL145483A0 (tr)
MX (1) MXPA01010144A (tr)
NO (1) NO328826B1 (tr)
NZ (1) NZ514445A (tr)
PE (1) PE20010030A1 (tr)
PL (1) PL219316B1 (tr)
PT (1) PT1171443E (tr)
RU (1) RU2248979C2 (tr)
TR (1) TR200102839T2 (tr)
TW (1) TW564247B (tr)
WO (1) WO2000061586A1 (tr)
ZA (1) ZA200107917B (tr)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1322651B1 (en) * 2000-09-22 2008-01-23 N.V. Organon Bicyclic heteroaromatic compounds
GB0100622D0 (en) 2001-01-10 2001-02-21 Vernalis Res Ltd Chemical compounds V111
DE10108481A1 (de) 2001-02-22 2002-10-24 Bayer Ag Pyridylpyrimidine
IL160194A0 (en) * 2001-09-04 2004-07-25 Akzo Nobel Nv GLYCINE-SUBSTITUTED THIENO [2,3-d] PYRIMIDINE WITH COMBINED LH AND FSH AGONISTIC ACTIVITY
TWI228508B (en) * 2001-09-04 2005-03-01 Akzo Nobel Nv Thieno[2,3-d]pyrimidines with combined LH and FSH agonistic activity
US6974870B2 (en) 2002-06-06 2005-12-13 Boehringer Ingelheim Phamaceuticals, Inc. Substituted 3-amino-thieno [2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
ES2318141T3 (es) 2002-06-06 2009-05-01 Boehringer Ingelheim Pharmaceuticals Inc. Compuestos de amida de acido 3-amino-tieno(2,3-b)piridina-2-carboxilico y procedimiento de preparacion y sus usos.
WO2004092177A1 (en) 2003-04-09 2004-10-28 Biogen Idec Ma Inc. Triazolopyrazines and methods of making and using the same
US7285550B2 (en) 2003-04-09 2007-10-23 Biogen Idec Ma Inc. Triazolotriazines and pyrazolotriazines and methods of making and using the same
ATE418555T1 (de) 2003-04-09 2009-01-15 Biogen Idec Inc A2a-adenosinrezeptorantagonisten
WO2005019225A1 (ja) * 2003-08-21 2005-03-03 Kyorin Pharmaceutical Co., Ltd. Ｎｋ１受容体拮抗作用を有する化合物の製造方法及びその製造中間体
US7550485B2 (en) * 2003-10-14 2009-06-23 Wyeth Substituted N-heterocycle derivatives and methods of their use
WO2005039506A2 (en) * 2003-10-24 2005-05-06 Exelixis, Inc. P70s6 kinase modulators and method of use
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
WO2006019832A1 (en) * 2004-07-22 2006-02-23 Ptc Therapeutics, Inc. Thienopyridines for treating hepatitis c
CA2630920A1 (en) * 2005-11-22 2007-05-31 University Of South Florida Inhibition of cell proliferation
TWI417095B (zh) 2006-03-15 2013-12-01 Janssen Pharmaceuticals Inc １，４-二取代之３-氰基-吡啶酮衍生物及其作為ｍＧｌｕＲ２-受體之正向異位性調節劑之用途
WO2007136776A2 (en) * 2006-05-17 2007-11-29 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Pyrimidine low molecular weight ligands for modulating hormone receptors
CA2653654A1 (en) 2006-06-06 2007-12-21 Boehringer Ingelheim International Gmbh Substituted 3-amino-thieno[2,3-b] pyridine-2-carboxamide compounds, their preparation and use
RU2444524C2 (ru) * 2006-08-21 2012-03-10 Дженентек, Инк. Азабензотиофенильные соединения и способы применения
TW200845978A (en) 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
JP5133416B2 (ja) 2007-09-14 2013-01-30 オルソー−マクニール−ジャンセン ファーマシューティカルズ， インコーポレイテッド． １’，３’−二置換−４−フェニル−３，４，５，６−テトラヒドロ−２ｈ，１’ｈ−［１，４’］ビピリジニル−２’−オン
US8722894B2 (en) * 2007-09-14 2014-05-13 Janssen Pharmaceuticals, Inc. 1,3-disubstituted-4-phenyl-1H-pyridin-2-ones
AU2008297876B2 (en) 2007-09-14 2011-07-07 Addex Pharma S.A. 1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones
EP2205608B1 (en) * 2007-10-18 2013-05-08 Boehringer Ingelheim International GmbH Preparation of dihydrothieno[3, 2-d]pyrimidines and intermediates used therein
CN101861316B (zh) 2007-11-14 2013-08-21 奥梅-杨森制药有限公司 咪唑并[1,2-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
EP2344470B1 (en) 2008-09-02 2013-11-06 Janssen Pharmaceuticals, Inc. 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
CN102186477B (zh) 2008-10-16 2013-07-17 奥梅-杨森制药有限公司 作为代谢型谷氨酸受体调节剂的吲哚和苯并吗啉衍生物
CN102232074B (zh) 2008-11-28 2014-12-03 奥梅-杨森制药有限公司 作为代谢性谷氨酸盐受体调节剂的吲哚和苯并噁嗪衍生物
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
RS53075B (en) 2009-05-12 2014-04-30 Janssen Pharmaceuticals Inc. 1,2,4-TRIAZOLO [4,3-A] PYRIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OR PREVENTION OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS
BRPI1010831A2 (pt) 2009-05-12 2016-04-05 Addex Pharmaceuticals Sa derivados de 1,2,4-triazolo[4,3-a]piridina e seu como moduladores alostéricos positivos de receptores de mglur2
AU2011328195B2 (en) 2010-11-08 2015-04-02 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
CA2815002C (en) 2010-11-08 2019-10-22 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
PT2649069E (pt) 2010-11-08 2015-11-20 Janssen Pharmaceuticals Inc Derivados de 1,2,4-triazolo[4,3-a]piridina e sua utilização como moduladores alostéricos positivos de recetores mglur2
RU2014103185A (ru) 2011-07-18 2015-08-27 Артс Байолоджикс А/С Биологически активное соединение на основе лютеинизирующего гормона (lh) с пролонгированным действием
MX355088B (es) 2011-11-23 2018-04-04 Cancer Research Tech Ltd Inhibidores de tienopirimidina de proteina cinasa c atipica.
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
KR20220051273A (ko) 2014-01-21 2022-04-26 얀센 파마슈티카 엔.브이. 대사 조절형 글루탐산 작동성 수용체 제2아형의 양성 알로스테릭 조절제 또는 오르토스테릭 작동제를 포함하는 조합 및 그 용도
IL279202B2 (en) 2014-01-21 2023-09-01 Janssen Pharmaceutica Nv Combinations containing positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic subtype 2 receptor and their use
CN107602585A (zh) * 2017-10-23 2018-01-19 遵义医学院 噻吩并吡啶双杂环化合物的制备工艺
BR102019022529A2 (pt) * 2019-10-25 2021-05-04 Anhanguera Educacional Ltda. Processo para obtenção de composições farmacêuticas antitumorais através de butadienos push-pull, compostos e seus usos

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993013664A2 (en) 1992-01-11 1993-07-22 Schering Agrochemicals Limited Biheterocyclic fungicidal compounds
TW449600B (en) 1994-04-19 2001-08-11 Takeda Chemical Industries Ltd Condensed-ring thiophene derivatives, their production and use
JP3854648B2 (ja) * 1994-04-19 2006-12-06 武田薬品工業株式会社 縮合チオフェン誘導体、その製造法及び用途
DE69528470T2 (de) 1994-11-08 2003-08-21 Takeda Chemical Industries Ltd Thienopyridin und thienopyrimidinderivate und ihre verwendung als entzündungshemmende mittel
CN1063446C (zh) * 1995-10-19 2001-03-21 武田药品工业株式会社 作为促性腺激素释放激素拮抗剂的噻吩并吡啶衍生物
JPH09169766A (ja) * 1995-10-19 1997-06-30 Takeda Chem Ind Ltd チエノピリジン誘導体，その製造法および用途
JPH09169767A (ja) * 1995-10-19 1997-06-30 Takeda Chem Ind Ltd 複素環化合物、その製造法および用途
EP0900222A1 (en) 1996-04-26 1999-03-10 Takeda Chemical Industries, Ltd. Thienopyridine derivatives, their production and use

Also Published As

Publication number Publication date
ID30502A (id) 2001-12-13
ZA200107917B (en) 2003-09-23
HK1041266A1 (en) 2002-07-05
HK1041266B (zh) 2005-09-16
DE60021262D1 (de) 2005-08-18
EP1171443A1 (en) 2002-01-16
PL219316B1 (pl) 2015-04-30
ATE299507T1 (de) 2005-07-15
ES2245304T3 (es) 2006-01-01
CN1177848C (zh) 2004-12-01
PT1171443E (pt) 2005-11-30
NO20014824D0 (no) 2001-10-04
DK1171443T3 (da) 2005-11-07
JP2002541259A (ja) 2002-12-03
IL145483A (en) 2007-06-03
CN1349535A (zh) 2002-05-15
PE20010030A1 (es) 2001-01-27
AU772258B2 (en) 2004-04-22
AU3816600A (en) 2000-11-14
WO2000061586A1 (en) 2000-10-19
CZ300832B6 (cs) 2009-08-19
RU2248979C2 (ru) 2005-03-27
NO20014824L (no) 2001-10-04
CA2368834C (en) 2009-11-03
HUP0200653A2 (en) 2002-06-29
US6841553B2 (en) 2005-01-11
CZ20013605A3 (cs) 2002-03-13
PL350964A1 (en) 2003-02-24
MXPA01010144A (es) 2002-04-24
US20030212081A1 (en) 2003-11-13
NZ514445A (en) 2003-07-25
BR0009558A (pt) 2002-02-19
BRPI0009558B1 (pt) 2016-10-25
IL145483A0 (en) 2002-06-30
CA2368834A1 (en) 2000-10-19
TW564247B (en) 2003-12-01
AR028474A1 (es) 2003-05-14
HU229002B1 (en) 2013-07-29
HUP0200653A3 (en) 2004-07-28
DE60021262T2 (de) 2006-01-05
CO5160348A1 (es) 2002-05-30
EP1171443B1 (en) 2005-07-13
KR20010103801A (ko) 2001-11-23
KR100691546B1 (ko) 2007-03-12
NO328826B1 (no) 2010-05-25
US6569863B1 (en) 2003-05-27
JP4854856B2 (ja) 2012-01-18

Similar Documents

Publication Publication Date Title
TR200102839T2 (tr) LH agonistleri olarak faydalı bisiklik heteroaromatik bileşikler.
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
SE9903998D0 (sv) New compounds
DE69823843D1 (de) Benzimidazolinone, benzoxazolinone, benzopiperazinone, indanone und deren derivate als faktor xa inhibitoren
RS50807B (sr) 3,11 b-cis-dihidrotetrabenazin za lečenje šizofrenije i drugih psihoza
TR200103186T2 (tr) MEK enzimlerinin inhibitörleri olarak kinolin türevleri
SE0202463D0 (sv) Novel compounds
BG106585A (en) Kinase inhibitors as therapeutic agents
CA2260337A1 (en) Therapeutic agents
ATE302775T1 (de) Carbolinderivate
TR200103460T2 (tr) 5-Fenil-pirimidin türevleri
CA2382406A1 (en) Substituted 2-arylbenzazole compounds and their use as antitumour agents
TR200002605T2 (tr) Nitrik oksit sentaz inhibitörleri olarak faydalı halojene amidino amino asit türevleri
AP2002002664A0 (en) Cyclohexylamine derivative as subtype selective NMDA receptor antagonists.
SE9903997D0 (sv) New compounds
ES2421948T3 (es) Compuestos y composiciones para suministrar agentes activos
BR0007864A (pt) Composto, e, uso de um composto
ATE359791T1 (de) Pyrimidin-2,4-dion-derivate als matrix- metalloproteinase-hemmer
AR032432A1 (es) Combinaciones oncoliticas para el tratamiento de cancer
HRPK20040372B3 (en) Crystalline sodium salt of telmisartan and the use of the same as an angiotensin antagonist
TR200001452T2 (tr) Bifenilamidin türevleri.
AP2002002697A0 (en) Biciclic cyclohexylamines and their use as NMDA receptor antagonists.
RS20060072A (en) Aminoquinoline derivatives and their use as adenosine a3 ligands
AU2001263130A1 (en) Bicyclic cyclohexylamines and their use as nmda receptor antagonists
CA2412596A1 (en) Cyclic gmp-specific phosphodiesterase inhibitors